Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
Hematology/Oncology Clinics of North America|January 11, 2005
Vitamin K antagonists and direct thrombin inhibitors: present and futureGraham F Pineo, Russell D HullEuropean Journal of Medical Research|June 24, 2004
Dalteparin: pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic diseasesGraham F Pineo, Russell D HullClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 13, 2009
Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patientsGraham F Pineo, Russell D HullSeminars in Thrombosis and Hemostasis|April 16, 2004
Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?Russell D Hull, Graham F PineoClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 29, 2005
Low-molecular-weight heparin for the treatment of venous thromboembolism in the elderlyGraham F Pineo, Russell D HullExpert Opinion on Pharmacotherapy|December 4, 2003
Tinzaparin in the treatment of venous thromboembolismGraham F Pineo, Russell D HullThe American Journal of Medicine|July 29, 2009
Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndromeRussell D Hull, Graham F Pineo, Rollin Brant, et al.Current Opinion in Pulmonary Medicine|July 31, 2008
Prevention of venous thromboembolism after ischemic strokeCarlos S Kase, Graham F PineoClinicoeconomics and Outcomes Research : CEOR|May 10, 2012
The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patientsGraham F Pineo, Jay Lin, Lieven AnnemansThe American Journal of Medicine|January 9, 2007
Self-managed long-term low-molecular-weight heparin therapy: the balance of benefits and harmsRussell D Hull, Graham F Pineo, Rollin F Brant, et al.Pageof 9